Decreased expression of MT1E is a potential biomarker of prostate cancer progression
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.18683
Abstract: Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR)… read more here.
Keywords: prostate; pca; expression; decreased expression ... See more keywords